Walke et al., 2023 - Google Patents
Challenges in, and recommendations for, hyperspectral imaging in ex vivo malignant glioma biopsy measurementsWalke et al., 2023
View HTML- Document ID
- 2315068556320674053
- Author
- Walke A
- Black D
- Valdes P
- Stummer W
- König S
- Suero-Molina E
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
The visualization of protoporphyrin IX (PPIX) fluorescence with the help of surgical microscopes during 5-aminolevulinic acid-mediated fluorescence-guided resection (FGR) of gliomas is still limited at the tumor margins. Hyperspectral imaging (HI) detects PPIX more …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6491—Measuring fluorescence and transmission; Correcting inner filter effect
- G01N2021/6493—Measuring fluorescence and transmission; Correcting inner filter effect by alternating fluorescence/transmission or fluorescence/reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3155—Measuring in two spectral ranges, e.g. UV and visible
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/0059—Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koller et al. | Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers | |
Koch et al. | Tackling standardization in fluorescence molecular imaging | |
Walke et al. | Challenges in, and recommendations for, hyperspectral imaging in ex vivo malignant glioma biopsy measurements | |
Valdés et al. | Quantitative, spectrally-resolved intraoperative fluorescence imaging | |
Valdes et al. | δ-aminolevulinic acid–induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy | |
Pekmezci et al. | Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology | |
Bravo et al. | Hyperspectral data processing improves PpIX contrast during fluorescence guided surgery of human brain tumors | |
JP6247316B2 (en) | Imaging system with hyperspectral camera guide probe | |
Lee et al. | Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity | |
Black et al. | Characterization of autofluorescence and quantitative protoporphyrin IX biomarkers for optical spectroscopy-guided glioma surgery | |
Sadda et al. | A pilot study of fluorescence lifetime imaging ophthalmoscopy in preclinical Alzheimer’s disease | |
Molina et al. | 5-Aminolevulinic acid-induced porphyrin contents in various brain tumors: implications regarding imaging device design and their validation | |
Nazeer et al. | Fluorescence spectroscopy as an efficient tool for staging the degree of liver fibrosis: an in vivo comparison with MRI | |
Kaibori et al. | Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma | |
Jeong et al. | Time-resolved fluorescence microscopy with phasor analysis for visualizing multicomponent topical drug distribution within human skin | |
Thong et al. | Clinical application of fluorescence endoscopic imaging using hypericin for the diagnosis of human oral cavity lesions | |
Van Hese et al. | The diagnostic accuracy of intraoperative differentiation and delineation techniques in brain tumours | |
Leiloglou et al. | Indocyanine green fluorescence image processing techniques for breast cancer macroscopic demarcation | |
Du et al. | Hyperspectral imaging and characterization of allergic contact dermatitis in the short‐wave infrared | |
Kosugi et al. | Method for diagnosing neoplastic lesions by quantitative fluorescence value | |
Xie et al. | Wide-field spectrally resolved quantitative fluorescence imaging system: toward neurosurgical guidance in glioma resection | |
Gomes et al. | Magnetic resonance imaging texture analysis to differentiate ameloblastoma from odontogenic keratocyst | |
Suero Molina et al. | Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology | |
US20210239617A1 (en) | Device and method for determining depth and concentration of a subsurface fluorescent object | |
White et al. | Simultaneous blood flow measurement and dermoscopy of skin lesions using Dual-Mode dermascope |